To address this, we established 4T1 BC cells in which c-Met was stably silenced by specific shRNA for c-Met (4T1/sh c-Met) and 4T1 BC cells in which scrambled shRNA was infected (4T1/sh control) as control. Here, MET is linked to breast cancer.